Skip to main content

Year: 2026

LGI Homes Introduces New Community in Greenville, SC

The Arcadia plan by LGI HomesThe three-bed, 2-bath Arcadia Floorplan by LGI Homes at Waters Farm.GREENVILLE-SPARTANBURG, S.C., April 13, 2026 (GLOBE NEWSWIRE) — LGI Homes, Inc. (NASDAQ: LGIH) proudly announces Waters Farm, an exciting new community in Woodruff, South Carolina, offering beautifully crafted single-family homes. Located in the welcoming town of Woodruff, Waters Farm offers small-town charm with convenient access to large city amenities throughout the Greenville-Spartanburg area. Positioned just a short drive from both Greenville and Spartanburg, Waters Farm offers residents easy access to the area’s best parks, dining, and shopping destinations. The community is also an easy commute to leading regional employers, including BMW Manufacturing, GE, and Michelin, providing strong job opportunities and economic...

Continue reading

B2Gold First Quarter 2026 Results – Conference Call Details

VANCOUVER, British Columbia, April 13, 2026 (GLOBE NEWSWIRE) — B2Gold Corp. (TSX: BTO, NYSE AMERICAN: BTG, NSX: B2G) (“B2Gold” or the “Company”) will release its first quarter 2026 financial and operational results after the North American markets close on Wednesday, May 6, 2026. B2Gold executives will host a conference call to discuss the results on Thursday, May 7, 2026, at 8:00 am PT / 11:00 am ET. Participants may register for the conference call here: registration link. Upon registering, participants will receive a calendar invitation by email with dial in details and a unique PIN. This will allow participants to bypass the operator queue and connect directly to the conference. Registration will remain open until the end of the conference call. Participants may also dial in using the numbers below:Toll-free in U.S. and Canada:...

Continue reading

Hubbell to Announce First Quarter 2026 Results on April 30, 2026

Shelton, CT, April 13, 2026 (GLOBE NEWSWIRE) — Hubbell Incorporated (NYSE: HUBB) today announced it will release its first quarter 2026 financial results prior to the opening of the market on April 30th, 2026. The Company will then webcast its Analysts’ Conference Call to discuss the results at 10:00 AM ET.  The full text of the press release announcing the results will be posted on Hubbell’s corporate website under the Press Release section. You can also access this information by going to www.hubbell.com and selecting “Investors” from the options at the bottom of the page and then “Press Releases” from the drop-down menu.  The live audio of the conference call and accompanying materials will also be available and can be accessed by visiting Hubbell’s Events and Presentations section. You...

Continue reading

Genco Shipping & Trading Issues Statement Regarding Diana Shipping’s Letter to Shareholders

NEW YORK, April 13, 2026 (GLOBE NEWSWIRE) — Genco Shipping & Trading Limited (NYSE:GNK) (“Genco” or the “Company”), the largest U.S.-headquartered drybulk shipowner focused on the global transportation of commodities, today issued the following statement regarding Diana Shipping Inc.’s (“Diana”) letter to Genco shareholders: The Genco Board of Directors and management team are committed to maximizing value for Genco shareholders. Today, Diana issued a letter as part of its efforts to take control of Genco through an inadequate acquisition proposal and through replacing the entire Genco Board with its handpicked nominees. We encourage shareholders to ignore Diana’s letter and not be distracted by its inflammatory and misleading statements. Instead, Genco shareholders should keep in mind the following:Genco’s comprehensive...

Continue reading

XORTX Announces Closing of Acquisition of Vectus Kidney Anti-fibrotic Asset

• VB4-P5 – novel new chemical entity with potential to address significant unmet need in rare and large-market chronic kidney disease • CALGARY, Alberta, April 13, 2026 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and progressive kidney disease, is pleased to announce the closing of the acquisition of the Vectus kidney anti-fibrotic asset (the “Acquisition”). The Company announced that it entered a binding term sheet on October 17, 2025 to acquire a Renal Anti-Fibrotic Therapeutic Program (the “Program”) from Vectus Biosystems Limited, an Australian Securities Exchange listed company (“Vectus”) and provided timing updates on December 31, 2025 and...

Continue reading

BioAge Labs to Present at 25th Annual Needham Virtual Healthcare Conference

EMERYVILLE, Calif., April 13, 2026 (GLOBE NEWSWIRE) — BioAge Labs, Inc. (NASDAQ: BIOA) (“BioAge”, “the Company”), a clinical-stage biotechnology company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging, today announced that the Company will present at the 25th Annual Needham Virtual Healthcare Conference taking place April 13–16, 2026. Kristen Fortney, PhD, CEO and co-founder, is scheduled to participate in a fireside chat on Thursday, April 16 from 3:00 PM to 3:30 PM EDT. Kristen Fortney, Dov Goldstein, MD, CFO, and BJ Sullivan, PhD, Chief Strategy Officer, will participate in one-on-one meetings. To access the live webcast of the presentation, register here. Replays of the webcast will be available in the investor section of the Company’s website...

Continue reading

Rezolve Ai to Host Investor Call: The $700M+ Case for Combining with Commerce.com

NEW YORK, April 13, 2026 (GLOBE NEWSWIRE) — Rezolve Ai PLC (NASDAQ: RZLV), the global leader in AI-native commerce infrastructure, today announced it will host an investor call and Q&A open to shareholders of both Rezolve Ai and Commerce.com, Inc. (NASDAQ: CMRC) on Wednesday, April 15, 2026, at 0800 Eastern Time. The call will be hosted by Daniel M. Wagner, Chairman and CEO of Rezolve Ai, and will follow the agenda below:Introduction to Rezolve Ai: the company, its technology platform and its financial trajectory Overview of the proposed combination with Commerce.com: the strategic rationale for the proposed offer The opportunity ahead: the value creation path and what it means for shareholders of both companies Open Q&ACommerce.com is guiding for as little as 1.5% revenue growth in the year ahead. Rezolve Ai is on...

Continue reading

Datacentrex Reports Full Year 2025 Results; Achieves Positive Adjusted EBITDA in Transformational Year

Cash and digital assets exceed $59 million as of the date of this releaseRevenue of approximately $7.0 million and gross profit of approximately $3.4 millionGenerated positive Adjusted EBITDA of approximately $0.5 million for the year (a non-GAAP measure)SALT LAKE CITY, April 13, 2026 (GLOBE NEWSWIRE) — Datacentrex, Inc. (“Datacentrex” or the “Company”) (Nasdaq: DTCX), a diversified technology-driven enterprise operating a digital asset mining business, today announced the filing of its Annual Report on Form 10-K for the fiscal year ended December 31, 2025. For the year, the Company generated revenue of approximately $7.0 million, gross profit of approximately $3.4 million, and positive Adjusted EBITDA of approximately $0.5 million, despite absorbing substantial one-time costs associated with the completion of its December...

Continue reading

Spyre Therapeutics Announces Proposed Public Offering of its Common Stock

WALTHAM, Mass., April 13, 2026 (GLOBE NEWSWIRE) — Spyre Therapeutics, Inc. (“Spyre” or the “Company”) (Nasdaq: SYRE), a clinical-stage biotechnology company advancing best-in-class antibody engineering, dose optimization, and rational therapeutic combinations for the treatment of Inflammatory Bowel Disease (“IBD”) and other immune-mediated diseases, today announced that it has commenced an underwritten public offering of $300.0 million of shares of its common stock. In addition, the Company is expected to grant the underwriters of the offering an option for a period of 30 days to purchase an additional $45.0 million of shares of common stock at the public offering price, less the underwriting discount. All of the shares of common stock in the offering will be sold by Spyre. The offering is subject to market and other conditions,...

Continue reading

One and One Green Technologies. INC Announces Closing of $13 Million Follow-on Offering

SAN RAFAEL, BULACAN, PHILIPPINES, April 13, 2026 (GLOBE NEWSWIRE) — One and one Green Technologies. INC (Nasdaq: YDDL) (“One and One” or the “Company”) (NASDAQ: YDDL), a Philippines-based recycler holding a government-issued license in the Philippines to import and process hazardous waste as raw materials, today announced the closing of its previously announced follow-on offering to two institutional investors for the sale of 1,733,334 units (the “Units”) in a follow-on offering of its securities at a purchase price of $7.50 per Unit, each unit consisting of one Class A ordinary share, par value $ 0.0001 per share (“Class A Ordinary Share”), and one warrant (“Warrant”) to purchase one and a half Class A Ordinary Shares (together, the “Securities”). The gross proceeds from the offering were $13 million, before deducting...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.